Transcription factors (TFs) are often used repeatedly during development and homeostasis to control distinct processes in the same and/or different cellular contexts.
Introduction
In the mammalian genome, there are approximately 1500 transcription factors (TFs) (Zhou et al. 2017; Vaquerizas et al. 2009 ), which bind to specific DNA sequences, within cis-regulatory modules (CRMs), to control gene expression and regulate almost every aspect of life. Many are used repeatedly, and in a variety of combinations, to regulate distinct developmental and homeostatic events. For instance, a handful of TFs, including Pax6, Ptf1a, Sox9, Hnf6 (Onecut1) and NeuroD1, regulate pancreatic development as well as retinal development (Bastidas-Ponce et al. 2017; Emerson et al. 2013; Poché et al. 2008, 9; Ohsawa and Kageyama 2008) . Moreover, within the same organ, TFs can be expressed in mitotic cells, newly postmitotic cells, and mature cells to regulate development as well as function. The reuse of a limited pool of TFs in different cellular contexts likely evolved to maximize their utility in driving the evolution of an amazingly diverse set of cell types and functions. A full definition of how specificity and function are created through the redeployment of TFs is an area of interest in many systems.
The murine neural retina has served as a model system for studying the development of a complex mammalian tissue (Cepko et al. 1996) . Access to the developing retina using in vivo electroporation has provided a strong platform for studies of gene regulation, as well as cell fate determination Cepko 2007, 2004) .
The developmental role and regulation of Otx2, a homeobox TF that is important in multiple aspects of retinal development, has been the subject of several such studies.
Otx2 is expressed in retinal progenitor cells (RPCs), the mitotic cells of the retina. RPCs that express Otx2 are a subset of those that are about to produce postmitotic daughter cells (Muranishi et al. 2011; Trimarchi et al. 2008 ). In addition, Otx2 is expressed in mature photoreceptor cells, the rods and cones, as well as in mature bipolar interneurons (Koike et al. 2007; Fossat et al. 2007) . Otx2 has been shown to be required for the genesis of photoreceptor cells, bipolar cells, as well as a type of interneuron, horizontal cells, which do not express Otx2 (Koike et al. 2007; Nishida et al. 2003; Sato et al. 2007 ). The dosage of Otx2 is important for the determination of rods vs. bipolar interneurons (Wang et al. 2014) , as well as for survival and activity of mature photoreceptors, bipolar cells, and horizontal cells (Housset et al. 2013; Béby et al. 2010; Bernard et al. 2014) . Overexpression of Otx2 in neonatal mouse retinas in vivo, when rods and bipolar cells are being generated, was found to increase the production of bipolar cells at the expense of rod photoreceptors. Knocking down Otx2 levels via shRNA led to the formation of more rods and fewer bipolar cells (Wang et al. 2014) . These Several studies of the regulation of Otx2 during retinal development have been carried out. One CRM, "EELPOT", can recapitulate Otx2 expression in embryonic mouse retinas (Muranishi et al. 2011) . It is positively regulated by Rax and negatively regulated by the Notch signaling pathway. Another CRM, designated ECR2, recapitulates Otx2 expression in a subset of neonatal RPCs and their newly postmitotic daughters (Emerson and Cepko 2011 ). ECR2 has not been characterized regarding its TF binding sites (TFBSs) or cognate TFs. In addition, three DNaseI hypersensitive genomic fragments flanking the Otx2 gene have been shown to be active in the neonatal mouse retina (Wilken et al. 2015) , though their upstream TFs and expression 5 patterns were not characterized. Despite these previous studies, the CRMs that regulate Otx2 expression in mature photoreceptor and bipolar cells are currently unknown. In addition to regulation in these various cell types, the regulation of expression levels of Otx2 is of interest. As rod and cone photoreceptors differentiate, the Otx2 level decreases, while it increases in bipolar cells, and disappears in differentiating horizontal cells (Trimarchi et al. 2008; Koike et al. 2007; Fossat et al. 2007; Baas et al. 2000) . Dose is also important for the survival and function of mature retinal cells, as alleles that reduce the level and activity of Otx2 lead to retinal degeneration (Bernard et al. 2014) .
To elucidate the regulation of Otx2 in different cellular contexts, we systematically searched for candidate CRMs for Otx2 using the DNaseI hypersensitivity of genomic regions within 350 kb of the Otx2 gene. Candidates were tested for CRM activity, and seven novel Otx2 CRMs were identified. Three of these CRMs, designated O5, O7 and O9, were found to drive strong expression in the postnatal retina in vivo. O5 drives expression primarily in mature bipolar cells. O7 drives expression in mature rods, while O9 drives expression in developing neonatal cells. These three CRMs thus recapitulate Otx2 expression in distinct cell types and at different stages. We further explored the TF binding sites (TFBSs) and TFs that regulate these CRMs, and discovered that Otx2, Crx and Sox2 can bind to and activate O5, O7, or O9 respectively. We also examined the endogenous chromatin status of O5, O7 and O9 CRMs in different retinal cell types, and found that these three CRMs show different chromatin states in different cell types. We conclude that the expression of Otx2 in different retinal cellular contexts is not regulated by common regulators. The chromatin accessibility and presence of particular TFs 6 together ensure the expression of Otx2 in a cell type-and stage-specific manner in the retina.
Results

Identification of active CRMs for the Otx2 gene based on chromatin status
CRMs have been nominated using a variety of methods and features. Chromatin accessibility and histone modifications are two such features (Klemm et al. 2019 (Billings et al. 2010) . When tested in newly explanted retinas ex vivo, seven of the DNaseI HS regions (O5, O7, O9, O10, O11, O15, and O20) drove significant expression of the reporter gene ( Figure 1) . Although the precise sequences of the three CRMs reported by Wilken et al. are not available, based on the approximate coordinates, the O5 and O9 CRMs may overlap with their DHS-2 and DHS-4.
We tested the activity of these seven CRMs in vivo by electroporating individual reporter plasmids into mouse retinas at postnatal day 0 (P0) ( Figure 2 ). Electroporation tends to result in expression in RPCs and their postmitotic progeny, which in the neonatal period become primarily rods and bipolar cells, with a small number of amacrine interneurons and Müller glial cells (Matsuda and Cepko 2007; Young 1985) . Plasmids can be retained in these mature cell types, allowing for a read out of activity in multiple cell types and their RPCs. Retinas were thus harvested at P3 or P14 to examine the activities of these CRMs in developing and mature retinal cells, respectively. The O10, O11, O15 and O20 CRMs were found to drive GFP expression in vivo, but were relatively weak (data not shown), and were not investigated further.
At P3, the O5, O7 and O9 CRMs were found to direct strong GFP expression, mimicking the endogenous expression of Otx2 ( Figure 2B ). More than 97% of the GFP+ cells were positive for Otx2 protein expression, as detected using immunohistochemistry (IHC) (Figure 2, B19 ). O5, O7 and O9 CRMs were active in approximately 16%, 42% and 10% of the electroporated cells that were Otx2+ (BFP+Otx2+ cells) at P3, respectively (Figure 2, B20). Co-electroporation of multiple CRMs driving different fluorescent proteins revealed that there was a significant number of cells simultaneously expressing the reporters driven by two or all three of these CRMs ( Supplementary Figure 1 ). We estimated that O5, O7 and/or O9 CRMs were collectively expressed in approximately 50% of the Otx2+ cells at P3 (Supplementary Figure 1J ).
As Otx2 has been shown to be expressed in the G2-M phase of the last cell cycle in a subset of RPCs (Trimarchi et al. 2008 ), the expression driven by the CRMs was examined in mitotic cells. First, to confirm that a subset of RPCs expresses Otx2, we examined the expression of Otx2 protein in cells labelled by EdU, a S-phase marker (Buck et al. 2008) , or Ki67, a pan-cell cycle marker (Scholzen and Gerdes 2000) . A small subset of Otx2+ cells were found to be EdU+ (<2%, 30min EdU pulse, Supplementary Figure 2A-C & G) or Ki67+ (< 15%, Supplementary Figure 2D -F & H). The O5 and O7 CRMs were found to be less active in EdU+ cells, while the O9 CRM preferentially marked the Otx2+ cells that were cycling at P3 (Supplementary Figure 2) . These data indicate that the O5, O7 or O9 CRMs mark overlapping, but distinct, populations of cells that express Otx2 in the neonatal mouse retina, with O9 being the most active in mitotic cells.
At P14, when the retinal is nearly fully developed, Otx2 is expressed at higher levels in bipolar cells, and relatively lower levels in photoreceptor cells (Figure 2 , C3). The O5
CRM was observed to mimic this pattern (Figure 2 , C1-6). In the inner nuclear layer (INL), the majority of O5-GFP+ cells were found to be cone bipolar cells, as recognized by the characteristic axonal projection pattern (Behrens et al.) . In addition, approximately 20% of O5-GFP+ cells in the INL were positive for PKCa ( Figure 2 , C7-15 & C29), a wellestablished marker of rod bipolar cells (Negishi et al. 1988; Shekhar et al. 2016) . Given that the estimated cone bipolar to rod bipolar ratio is about 2.6:1 in mouse retina (Strettoi et al. 2010) , the O5 CRM is biased towards labeling cone bipolar cells. In contrast, the activity of the O7 CRM was restricted to rod photoreceptors at P14 (Figure 2 Taken together, the O5, O7 and O9 CRMs direct expression recapitulating the endogenous Otx2 expression in different retinal cell populations and at different developmental stages. The O9 CRM preferentially labels Otx2+ RPCs and their newly postmitotic daughters, and its activity is silenced in differentiated cell types. In mature retinas (P14 or later), the O5 CRM drives expression predominantly in bipolar cells and in a relatively small subset of rods, and the O7 CRM directs expression only in rod photoreceptors.
The O5 CRM is required for expression of Otx2 in bipolar cells
In order to determine if the Otx2 CRMs identified above are necessary for endogenous Otx2 expression, we deleted them from the genome in vivo. We electroporated a Cas9 plasmid and appropriate single guide RNAs (sgRNAs) into the mouse retina in vivo for this purpose. Plasmids encoding sgRNAs targeting the 5' or 3' region of the O5 CRM, as well as O5-Cas9 (O5 CRM drove Cas9 expression) and CAG-mCherry plasmids, were co-electroporated into mouse retinas at P0 in vivo ( Figure 3A-B ). Previous studies have shown that there is a high efficiency of co-electroporating multiple plasmids into the same retinal cells in vivo Cepko 2004, 2007) . The retinas were harvested at P14 and the levels of endogenous Otx2 transcripts were detected and quantified by single molecule fluorescent RNA in situ hybridization (smFISH) (Raj et al. 2008; Wang et al. 2012 ). The number of smFISH puncta had been found to correlate well with mRNA levels.
We dissociated the retinas into single cell preparations to increase the accuracy of quantification. The electroporated cells that received the plasmid mix were labeled by mCherry ( Figure 3C -F). Bipolar cells were labeled by IHC for Chx10 (Vsx2). The number of Otx2 smFISH puncta in mCherry+Chx10+ bipolar cells with or without the O5 CRM deletion was quantified ( Figure 3G ). The number of bipolar cells with low Otx2 mRNA levels was significantly increased when the O5 CRM was deleted, demonstrating that the O5 CRM is necessary for the wild type level of Otx2 mRNA in bipolar cells.
Assay for the endogenous role of the O9 CRM was not successful. Due to the extended time needed to accumulate significant levels of Cas9 protein, and the fact that the O9 CRM is only transiently active in Otx2+ progenitor/precursor cells, we were not able to delete the O9 CRM quickly enough to assay its endogenous activity. Deletion of the O7 CRM by CRISPR did not result in significant down regulation of Otx2 mRNA levels (data not shown). Its function may be compensated by other Otx2 CRMs, such as O5, which has activity in rods (Figure 2 , C2).
Identification of TFBSs and TFs for O5, O7 or O9 activity
To understand how O5, O7 or O9 CRMs are regulated, we searched for TFBSs and TFs that are required for activation of these CRMs. We first determined the minimal sequences within each CRM that are required for CRM activity. The O5, O7 or O9 CRMs were truncated into smaller fragments based on the positions of bioinformatically predicted TFBSs (MotifDb, Shannon 2015, Grant et al. 2011) . Each fragment was individually cloned into the Stagia3 reporter and tested in mouse retinas ex vivo ( Figure   4A , C & E). The O5-8, O7-1 and O9-12 elements were found to drive strong expression of the AP reporter gene. We then mutated individual predicted TFBSs on O5-8, O7-1 or O9-12 to further investigate the identity of their cognate TFs. Mutating the Otx2 binding site (Otx2 BS) completely abolished the activity of the O5-8 CRM ( Figure 4B ). Mutation of the Crx binding site (Crx BS) reduced the activity of O7-1 element ( Figure 4D ). Mutating the Sox2 binding site (Sox2 BS) reduced the activity of the O9-12 element ( Figure 4F ).
The ability of Otx2, Crx or Sox2 to activate O5-8, O7-1 or O9-12 was further investigated in HEK293T cells in vitro, which do not normally activate the Otx2 CRMs. Otx2 was found to be sufficient to activate the wild type O5-8, but not the element with the Otx2 binding site mutation ( Figure 4G ). Crx and Sox2 behaved similarly on their respective elements ( Figure 4H -I). To examine whether Otx2, Crx or Sox2 directly binds to O5, O7 or O9 CRMs, we performed electrophoretic mobility shift assays (EMSA) ( Supplementary  Figure 3 ). The biotin-labeled CRMs were used as DNA probes. Strong electrophoretic mobility bands were detected when the CRM probes were mixed with TF-enriched nuclear extracts. When un-labeled cold probe or antibody was included, the primary EMSA band disappeared, suggesting that the binding was specific. These results demonstrate that Otx2, Crx or Sox2 can regulate O5, O7 or O9 CRMs via direct binding, and likely contribute to the cell type-and stage-specific activation of these CRMs.
To investigate if the expression patterns of Otx2, Crx and Sox2 match what would be predicted for their roles in regulating the Otx2 CRMs, we checked their patterns of expression by IHC. At neonatal stages, O5-GFP+, O7-GFP+, or O9-GFP+ cells were positive for Otx2, Crx or Sox2 respectively ( Figure 2B and Supplementary Figure 4 ).
However, not all Otx2+, Crx+, or Sox2+ electroporated cells turned on O5, O7 or O9 CRM by P3. This could be due to the levels of the TFs, which might not be high enough in certain retinal cells. To test this possibility, we over-expressed Otx2, Crx or Sox2 in P0 retinas electroporated by the CRM reporter plasmids. This led to increased numbers of cells that turned on O5, O7 or O9 CRM plasmids within 24 hours (Supplementary figure   5 ). These data suggest that Otx2, Crx or Sox2 can activate O5, O7 or O9 CRM reporters at neonatal stages, and the levels of these TFs may be important for CRM activity.
In mature retinas, Otx2 is expressed at higher levels in bipolar cells than in rods, which matches the pattern of O5-GFP expression ( Figure 2C ). Notably, compared with cone bipolar cells, rod bipolar cells express relatively lower levels of Otx2 (Supplementary Figure 6A -C). Consistent with this, the majority of O5-GFP+ bipolar cells had the morphology of cone bipolar cells (Figure 2 , C2), suggesting that the level of Otx2 is important for the expression pattern of O5 CRM activity in bipolar cells. Interestingly, Crx is expressed at a higher level in rods than in bipolar cells (Glubrecht et al. 2009; Shekhar et al. 2016) (Supplementary figure 6B) , and the O7-GFP, which requires a Crx binding site, was found to be active only in rods. It is possible that the level of Crx is not high enough to activate O7-GFP in bipolar cells. However, over-expression of Crx specifically in bipolar cells via the Chx164 bipolar CRM (Kim et al. 2008) , did not lead to activation of O7-GFP in bipolar cells (data not shown). Similarly, Sox2 is expressed in Müller glial cells in the adult retina ), but the O9-GFP CRM, which requires the Sox2 binding site, was not active in these cells at P14. We compared the levels of Sox2 in P3 retinal cells with those in P14 Müller glial cells by quantitative smFISH (Supplementary figure 6F-G). The mRNA level of Sox2 in mature Müller glial cells was found to be only slightly lower than that in RPCs at P3, suggesting that the level of Sox2 is not responsible for the loss of O9 activity in mature Müller glial cells. It is possible that unknown transcriptional repressors of O7 or O9 CRMs exist in mature bipolar or Müller glial cells, a hypothesis that needs to be investigated.
Taken together, O5, O7, or O9 CRMs are active in cells expressing Otx2, Crx or Sox2, but not all Otx2, Crx or Sox2 positive cells turn on the corresponding CRMs. The levels of TFs appear to be important for CRM activity at neonatal stages. In the differentiated retina, the activity of repressors, particularly in mature bipolar and Müller glia with respect to the O7 and O9 CRMs, may contribute to the regulation of the CRM activity.
Otx2, Crx and Sox2 are required for the activation of O5, O7 and O9 CRM in the retina.
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To investigate whether Otx2, Crx and Sox2 are required for O5, O7 and O9 activities in different retinal cell types at different stages in vivo, we used shRNA constructs to knock down these TFs. To test the necessity of Otx2 in bipolar cells for O5 activation, Otx2 was knocked down using a miRNA-based shRNA cassette, which was inserted into the 3' UTR of the mCherry gene (Wang et al. 2014) . To specifically target differentiated bipolar cells, we used the bipolar specific CRM, 164bp Chx10 CRM (Chx164) (Kim et al. 2008) . Even though the Chx164 CRM is biased towards labeling rod bipolar cells, i.e. less active in cone bipolar cells, it is the most effective driver for specific targeting of differentiated bipolar cells, and not RPCs, where Chx10 is also expressed. The Chx164-mCherry-Otx2-shRNA plasmid or control Chx164-mCherry-LacZ-shRNA plasmid was co-electroporated with the O5-GFP plasmid into P0 retinas in vivo. The retinas were harvested at P14 and the activity of the O5 CRM was assayed in cells marked by mCherry expression. The to be open. In Müller glial cells, the O5 and O7 CRMs were closed, and the O9 CRM was less accessible than in other cell types. Therefore, the endogenous O5, O7 and O9 CRMs have different chromatin accessibilities in different retinal cell types and at different stages during development.
Discussion
We analyzed the regulation of Otx2, a gene required for the formation of several retinal cell types at different times in development. We wished to understand not only how its temporal and cell type specific transcription are orchestrated, but also how its level is 15 controlled, given that its level can dictate whether a rod or a bipolar fate are chosen (Wang et al. 2014) as well as the survival and function of particular mature retinal cells (Bernard et al. 2014) . We first used plasmid electroporation of genomic regions defined by their chromatin accessibility to identify several CRMs, O5, O7, and O9. These elements showed differential activity regarding cell types and the timing of their expression. The binding sites that are required for CRM activity were defined and were used to successfully direct a search for the cognate TFs. The identified TFs were found to be necessary, but not sufficient, for the expression patterns of these CRMs. This led us to investigate the accessibility of the CRMs in the chromatin of particular cell types in vivo.
The O5, O7 and O9 CRMs were found to display differential chromatin accessibility in different cell types. Based on these data, we propose a model on how the stage-and cell type-specific expression of Otx2 is achieved in the retina ( Figure 7A ). Otx2 also is expressed in the retina at embryonic stages (Muranishi et al. 2011) .
We examined the activities of the candidate Otx2 CRMs (Figure 1 Different mechanisms may control the developmental silencing of these CRMs. The O6 and O8 CRMs are DNaseI hypersensitive in the postnatal retina, and thus it is likely that it is the absence of their TFs, which are currently unknown, that leads to their lack of activity. The EELPOT CRM is not DNaseI hypersensitive in the postnatal retina ( Figure   7B ), and thus may not be accessible by its TFs, such as Rax, which is present at postnatal stages. These data suggest that additional CRMs contribute to the regulation of Otx2 expression at embryonic stages, and that the silencing of embryonic CRMs at late stages is caused by chromatin remodeling and/or dynamic expression of TFs.
Apart from the retina, Otx2 is essential for early embryonic development and brain development Acampora 1999) . Several CRMs have been identified to control Otx2 expression in visceral endoderm (VE), anterior neuroectoderm (AN), cephalic mesenchyme (CM) and developing forebrain/midbrain (FM) (Kurokawa et al. 2004a (Kurokawa et al. , 2004b Kimura et al. 2000; Bryan 1997 ). The published VE and CM CRMs are located in the promoter region of the Otx2 gene, and partially overlap with the O15 CRM, which drives weak expression in the neonatal retina (Figure 1) . Interestingly, none of the other distal Otx2 CRMs are shared among tissues ( Figure 7B ). We examined the chromatin accessibility of the non-retinal Otx2 CRMs in the retina to investigate whether this is due to differential chromatin states. The published anterior neuroectoderm CRMs (AN1 and AN2) (Kurokawa et al. 2004b) are not significantly open in the postnatal retina, while two out of three mouse forebrain/midbrain CRMs (FM1 and FM3, corresponding to O19 and O22) (Kurokawa et al. 2004a ) are open, but inactive in the retina. This further suggests that the activities of the tissue-specific Otx2 CRMs are not only regulated by differential chromatin states, but also due to the availability of their TFs.
Taken together, the expression of Otx2 is regulated via many distinct CRMs and Second, how are the differential expression levels of Otx2 established in different cellular contexts? Otx2 is expressed at a low level in rod photoreceptors relative to the high level in bipolar cells. Its expression level is essential for the binary cell fate decision of these two cell types, with high expression driving bipolar formation (Wang et al. 2014) .
One of the ways to establish the differential expression levels of Otx2 could be via chromatin accessibility and/or TF activity. For this decision, our data argue for the level of TFs as one of the key determinants, as when we increase the level of Otx2, Crx or Sox2, the activity of O5, O7 or O9 CRM in the neonatal retina is increased. These TF dose effects could help to establish and maintain the differential expression levels of Otx2 in rod and bipolar cells. Specifically, the O5 CRM is strongly active in bipolar cells, which express high levels of the O5 regulator, Otx2, creating a feedforward loop, which likely maintains high Otx2 levels in bipolar cells. In contrast, the level of Otx2 in rod photoreceptors is low, likely not high enough to stimulate the self-reinforcement mechanism. Instead, Crx, which is highly expressed in rods, regulates Otx2 expression via the O7 CRM. Additional factors, which titrate down Otx2 levels in rod photoreceptor to prevent the feed-forward loop operating in bipolar cells, need to be identified to complete our understanding. Additional mechanisms, involving the Notch signaling pathway and TFs, including Blimp1 (Prdm1), Vsx2 and Sox2, contribute to the regulation of Otx2 expression in retinal progenitor cells and newly postmitotic cells (Muranishi et al. 2011; Wang et al. 2014; Kim et al. 2008 ). All of these factors will need to be integrated for the dynamic and specific regulation of Otx2 in different cellular contexts.
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Third, what are the advantages of using multiple TFs and CRMs to regulate Otx2 expression in different cellular contexts? This strategy can significantly increase the robustness of the system. When one CRM element is mutated or disrupted, other CRMs could compensate for its function. For instance, when the O7 CRM was deleted by CRISPR/Cas9, we did not observe significant down regulation of Otx2 transcription (data not shown). In addition, different cellular contexts probably maintain distinct regulatory environments. This strategy can ensure the activation of Otx2 in response to different signals, to maximize the utility of TFs in the genome.
In addition to the data regarding Otx2 regulation provided by these studies, the CRMs identified here provide reagents for labeling and manipulating distinct cell types in the retina via in vivo plasmid DNA electroporation. The O5 CRM is primarily active in cone bipolar cells, the O9 CRM in neonatal retinal progenitor cells and newly postmitotic cells, and the O7 CRM marks rod photoreceptors.
In summary, we studied how the expression of a key regulator of retinal development, Otx2, is regulated, in order to understand the specifics of its expression. In addition, we wished to gain some insight into the mechanisms that might more generally account for the dynamic and cell type specific regulation of a gene. We show that multiple CRMs and a cohort of TFs collectively control the stage-and tissue/cell type-specific expression of Otx2. The chromatin accessibility of CRMs and the presence of sequencespecific upstream TFs are both required for activating Otx2 expression in different cellular contexts. In the future, it will be important to investigate how the chromatin accessibility of CRMs are established and dynamically regulated across developmental and cellular states, and to understand how the TFs pools are maintained and regulated in different cellular contexts.
Methods and Materials
Animals
Wild type mouse neonates were obtained from time pregnant CD1 mice (Charles River Laboratories, #022). All animal studies were approved by Administrative Panel on Laboratory Animal Care (APLAC) at Stanford University.
Plasmid Construction
The CAG-mCherry plasmid was from Matsuda (Matsuda and Cepko 2004) . The Stagia3 vector was from Billings (Billings et al. 2010) . The CAG-BFP plasmid was from Tang (Tang et al. 2015) . All other plasmids were constructed by restrictive enzyme-based cloning or Gibson assembly methods (Gibson et al. 2009 ).
Otx2 CRM reporter plasmids (Figure 1) The 25 candidate Otx2 CRMs were amplified from the mouse genome by primers showed in Table 1 and cloned into the Stagia3 vector. The sequences of these CRMs were shown in supplementary file 1. CRISPR plasmids (Figure 3) To generate the O5-Cas9 plasmid, the Cas9 fragment was amplified by PCR from Px330 plasmid (Addgene # 42230) (Cong et al. 2013 ) and replaced the GFP fragment in the O5-GFP plasmid. To generate the O5-sgRNA1 and O5-sgRNA2 plasmids, the following corresponding complementary oligonucleotides were annealed and cloned into the modified Px330 plasmid, which does not express Cas9.
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O5-sgRNA1-f: 5'-TTG aacagccgacaaaacccgggGTTTAAGAGC O5-sgRNA1-r: 5'-TTAGCTCTTAAACcccgggttttgtcggctgttCAACAAG O5-sgRNA2-f: 5'-TTG gttctgcgggaccgccgttt GTTTAAGAGC O5-sgRNA2-r: 5'-TTAGCTCTTAAACaaacggcggtcccgcagaacCAACAAG CRM deletion analysis (Figure 4) The truncated CRM O5-1 to O5-x were amplified by PCR and cloned into the Stagia3 vector plasmid individually. Mutation variants of O5-8, O7-1, or O9-12 were generated by annealing complementary oligonucleotides of individual mutated fragments and ligating them into the EcoRI and XhoI digested Stagia3 plasmid. The sequences of the truncated and mutated CRMs are shown in Supplementary file 1.
Cell type-specific knockdown and over-expression of Otx2, Crx or Sox2 ( Figure 5) The Chx-mCherry-lacZ-shRNA or Chx-mCherry-Otx2-shRNA plasmid was generated by replacing the CAG promoter of the CAG-mCherry-lacZ-shRNA (Addgene #73978, (Wang et al. 2014) ) or CAG-mCherry-Otx2-shRNA (Addgene #73980, Wang et al. 2014 ) plasmid with the 164bp Chx10 CRM and basic TATA box promoter (Kim et al. 2008) . The Rho-mCherry-lacZ-shRNA or Rho-mCherry-Crx-shRNA plasmid was generated by replacing the CAG promoter of CAG-mCherry-lacZ-shRNA (Addgene #73978, Wang et al. 2014) or CAG-mCherry-Crx-shRNA (Addgene #73987, (Wang et al. 2014) The CAG-Sox2 plasmid was generated by cloning the ORF of mouse Sox2 gene into the CAG-GFP backbone (Addgene #11150, (Matsuda and Cepko 2004) . The GFP fragment was replaced by the Sox2 ORF. The CAG-filler-DNA plasmid was generated by deleting the GFP fragment from the CAG-GFP plasmid.
In vivo and ex vivo plasmid electroporation into the retina
Ex vivo and in vivo retina electroporations were carried out as previously described Cepko 2004, 2007; Wang et al. 2014) . For ex vivo electroporation, 5 pulses of 25V, 50ms each and 950ms interval were applied to dissected retinas. For in vivo electroporation, 5 pulses of 80V, 50ms each and 950ms interval were applied to neonatal mouse pups. All ex vivo and in vivo electroporation experiments were repeated with at least three biological replicates. Plasmids were electroporated with a concentration of 500ng/ul to 1ug/ul per plasmid.
Histology and immunohistochemistry
Dissected mouse eyeballs were fixed in 4% PFA in 1XPBS (pH7.4) for 2 hours at room temperature. Retinas then were dissected and equilibrated at room temperature in a series of sucrose solutions (5% sucrose in 1XPBS, 5min; 15% sucrose in 1XPBS, 15min; 30% sucrose in 1XPBS, 1 hour; 1:1 mixed solution of OCT and 30% sucrose in PBS, 4 degree, overnight), frozen and stored at -80°C. A Leica CM3050S cryostat (Leica Microsystems) was used to prepared 20um cryosections. Retinal cryo-sections were washed in 1XPBS briefly, incubated in 0.2% Triton, 1XPBS for 20 min, and blocked for 30 min in blocking solution, which is 0.1% Triton, 1% BSA and 10% Donkey Serum (Jackson ImmunoResearch Laboratories, Inc.) in 1XPBS. Slides were incubated with primary antibodies diluted in blocking solution in a humidified chamber at room temperature for 2 hours or at 4°C overnight. After washing in 0.1% Triton 1XPBS three times, slides were incubated with secondary antibodies and DAPI (Sigma-Aldrich; D9542) for 30min to 2 hours, washed three times with 0.1% Triton, 1XPBS and mounted in Fluoromount-G (Southern Biotechnology Associates).
The following primary antibodies were used: chicken anti-GFP (Abcam, AB13970, 1:1000), goat anti-RFP (Fisher Sicentific, NC1578084, 1:500), rabbit anti-Otx2 (VWR, 10091-640, 1:1000), rabbit anti-Crx (Fisher Scientific, NBP215964, 1:500), mouse anti-Ki67 (BD Biosciences, 550609, 1:200), sheep anti-Chx10 (Exalpha Biologicals, X1179P, 1:500), and mouse anti-Sox2 (Santa Cruz Biotechnology, sc-365823) antibodies. EdU detection was performed with a Click-iT EdU Alexa Fluor 647 imaging kit (C10340, Invitrogen). AP activity was detected by an AP detection kit (Sigma, SCR004).
Dissociation of retina tissues and quantitative single molecule FISH
Retinal tissues were dissociated as described previously (Trimarchi et al. 2008 ). After dissociation, retinal cells were left on PDL (Poly-D-Lysine, 0.1mg/ml, Millipore) treated slides for 45 min at 37°C. Retinal cells were then fixed on the slides in 4% PFA in 1XPBS (pH7.4) for 15min at room temperature. The cells were stained immediately or dehydrated by going through the 50%, 70% and 100% ethanol gradient, and stored in 100% ethanol at -20°C. FISH probes were purchased from RNAscope. The commercial protocol provided by RNAscope was followed. The slides were imaged by Zeiss confocal LSM 880. Images were analyzed by Zen software (Zeiss), and quantified by Fiji.
EMSA assay
EMSA assays were performed as described previously (Wang et al. 2014) . Roughly 1X10 6 293T cells were transfected with 1 μg of CAG-LacZ, CAG-Otx2, CAG-Crx, or CAG-Sox2 plasmid using PEI (1mg/ml, 4ul per 1μg DNA, 9002-98-6, Polysciences Inc).
Nuclear extracts were prepared from these cells or P3 mouse retinas using NE-PER nuclear and cytoplasmic extraction reagent kit (Pierce). Complementary oligonucleotides were ordered, annealed and labeled by DNA 3' End Biotinylation kit (Pierce).
Chemiluminescent Nucleic Acid Detection Module (Pierce) was used to detect biotinlabeled probes after EMSA assay.
Imaging and analysis
All images of retinal sections were acquired by a Zeiss LSM880 inverted confocal microscope. Retina explants were imaged by Leica M165 FC microscope. HEK293T cells were imaged by Zeiss Axio Observer 3 microscope. Images in Figure 2 , 3 and 5 were maximum projections of 5 μm tissues and were quantified by Fiji software.
TF binding sites prediction
To predict TF binding sites (TFBSs) located in CRMs, the Position Weight Matrix (PWM) annotated by MotifDB was used (Shannon, P. MotifDb: An Annotated Collection of Protein-DNA Binding Sequence Motifs v1.12.1, The R Foundation, 2015). Based on these PWM, FIMO (Grant et al. 2011 ) were used to search for potential TFBSs with the default cutoff E-value < 10 -4 .
DNase-seq and ATAC-seq and data analysis
We downloaded the BigWig file for DNase-seq of mouse newborn retina tissue from the ENCODE portal (https://doi.org/10.1093/nar/gkx1081) (https://www.encodeproject.org/) with the following identifier: ENCSR000CNV (Vierstra et al. 2014) . BigWig for rod photoreceptors was from (Hughes et al., 2017) O1  O2  O3  O4  O5  O6  O7  O8  O9  O10   O11  O12  O13  O14  O15  O16  O18  O19  O20  O21  O22  O23  O24   6720456H20Rik  Otx2  4933429O19Rik Retina 1week
Retina 8week
Retina 1day The minimal elements within O5 (A), O7 (C) or O9 (E), which were sufficient to drive reporter activity (AP signals), were discovered by creating deletion constructs of individual CRMs. Each CRM was truncated into smaller elements based on the availability of predicted TF binding sites. Each truncated element was incorporated into the Stagia3 reporter plasmid, and tested for its ability to drive AP expression in retinas ex vivo. CAG-mCherry plasmid was used as the electroporation efficiency control. Strong AP signals often absorbed the fluorescent mCherry signals (e.g. O5-2). Scale bar: 0. 5mm. (B, D & F) The Otx2, Crx or Sox2 binding sites were required for the activity of O5-8 (B), O7-1 (D) or O9-12 (F) elements, respectively. The mutation or deletion of these binding sites abolished reporter activity. Scale bar: 0.5 mm. (G, H & I) Otx2, Crx or Sox2 were sufficient for reporter activity in HEK293T cells. The CAG-mCherry plasmid was the transfection efficiency control. In the O5-8-mOtx2-GFP plasmid, the Otx2 binding site was mutated. In the O7-1-mCrx-GFP plasmid, the Crx binding site was mutated. In the O9-12-mSox2-GFP plasmid, the Sox2 binding site was mutated. Scale bar: 50um. or Otx2-shRNA (A2) were placed in the 3'UTR of mCherry, and driven by the Chx164 CRM (Kim et al. 2008) , which directs expression in mature bipolar cells. The shRNA-containing plasmid and O5-GFP plasmid were co-electroprated into retinas in vivo at P0. Retinas were harvested at P14. White arrows: mCherry+GFP+ positive cells. The percentage of mCherry+ cells that turned on the O5 CRM was quantified in A3. (B). Knocking down Crx in rods diminished O7 CRM activity. Control LacZ-shRNA (B1) or Crx-shRNA (B2) were placed in the 3'UTR of mCherry, and driven by the Rho promoter Cepko 2007, 2004) , which directs expression in mature rods. The shRNA-containing plasmid and O7 -GFP plasmid were co-electroprated into retinas in vivo at P0. Retinas were harvested at P14. (C). Knocking down Sox2 diminished O9 activity in retinal cells at P1. Control LacZ-shRNA (C2-C3) or Sox2-shRNA (C4) were placed in the 3'UTR of mCherry, and driven by the ubiquitous CAG promoter. The shRNAcontaining plasmids were electroprated into P0 retinas with the O9-GFP plasmid. The retinas were cultured ex vivo for 24 hours (C1). The percentage of mCherry+ cells that turned on the O9 CRM was quantified in C5. * P<0.01. T-test. Scale bar: 20um. 
